Gilead, Renown Institute for Health Innovation announce collaboration to advance understanding of NASH

This article was originally published here

Under the terms of the collaboration and license agreement, Gilead will provide funding to Renown IHI to sequence and analyze the DNA of 15,000 individuals living with NASH

The post Gilead, Renown Institute for Health Innovation announce collaboration to advance understanding of NASH appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply